Why is Bliss GVS Pharma falling/rising?

As of 17-Sep, Bliss GVS Pharma Ltd's stock price is currently at 152.70, reflecting an increase of 1.25, or 0.83%. The stock has shown a trend reversal by gaining after three consecutive days of decline. Despite this recent uptick, the stock has underperformed in the short term, with a 1-week return of -0.26% and a 1-month return of -9.62%. It is noteworthy that the stock's performance today outperformed its sector by 0.79%. However, there has been a decline in investor participation, with delivery volume falling by 31.13% against the 5-day average. The company maintains a low debt-to-equity ratio and has generated a return of 15.99% over the past year, although profits have decreased by 3.6%.
In the broader market context, the stock's recent performance contrasts with the Sensex, which has increased by 1.56% over the past week and 2.60% over the past month. While Bliss GVS Pharma has shown consistent returns over the last three years, its current price is trading at a premium compared to its peers' average historical valuations. This suggests that while the stock has potential due to its fair valuation and consistent performance, the recent declines in investor participation and profit margins may be contributing to its volatility in the short term.